Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Heptaplatin-paclitaxel º´ÇÕÇ׾Ͽä¹ýÀ¸·Î ¿ÏÀü °üÇØµÈ Á÷ÀåÀÇ Àç¹ß¼º º¹¸·¼º À¯µÎ»ó Àå¾×¼º ¾Ï Papillary Serous Carcinoma in Rectum-a Case of Complete Remission of Bulky Pelvic Disease after Platinum-paclitaxel Combination Chemotherapy

´ëÇÑ´ëÀåÇ×¹®ÇÐȸÁö 2002³â 18±Ç 6È£ p.419 ~ 422
ÃÖÁ¤ÈÆ, À±¼®Çö, À±¿ÏÈñ,
¼Ò¼Ó »ó¼¼Á¤º¸
ÃÖÁ¤ÈÆ ( Choi Jung-Hoon ) 
Ãæ³²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

À±¼®Çö ( Yoon Seok-Hyun ) 
Ãæ³²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
À±¿ÏÈñ ( Yoon Wan-Hee ) 
Ãæ³²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Abstract


Papillary serous carcinoma of the peritoneum (PSCP) is a primary tumor of peritoneal lining (mesothelioma) of the abdomen and is histologically difficult to differentiate from papillary serous carcinoma of the ovary. It is very rare tumor that
involves the surface of the pelvic and/or abdominal peritoneum. Most patients with this tumor have been treated with optimally surgical cytoreduction and postoperative chemotherapy. However, long term survival has not been achieved in many studies. In recent years, platinum-paclitaxel combination therapy was reported as a effective initial therapy for recurrent PSCP. We have experienced one case of recurrent PSCP which was successfully treated with heptaplatin and paclitaxel. We report the toxicity and long term result of the patient.

Å°¿öµå

Àç¹ß¼º À¯µÎ»ó Àå¾×¼º ¾Ï;Á¾±«°¨·®¼ú
Heptaplatin;Recurrent papillary serous carcinoma;Cytoreduction; Heptaplatin

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS